8.11
0.25%
0.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.06
Offen:
$8
24-Stunden-Volumen:
211.21K
Relative Volume:
0.03
Marktkapitalisierung:
$1.28B
Einnahmen:
$793.74M
Nettoeinkommen (Verlust:
$-398.71M
KGV:
-1.1171
EPS:
-7.26
Netto-Cashflow:
$-514.43M
1W Leistung:
+11.91%
1M Leistung:
-20.32%
6M Leistung:
-45.81%
1J Leistung:
+51.03%
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
NVAX | 8.1012 | 1.28B | 793.74M | -398.71M | -514.43M | -7.26 |
VRTX | 447.96 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 742.12 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 591.39 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 249.31 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 102.70 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
2023-01-09 | Bestätigt | B. Riley Securities | Buy |
2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
2022-12-02 | Eingeleitet | Jefferies | Hold |
2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
2022-05-20 | Eingeleitet | BofA Securities | Underperform |
2022-02-23 | Bestätigt | B. Riley Securities | Buy |
2022-02-22 | Fortgesetzt | Jefferies | Buy |
2022-01-21 | Eingeleitet | Cowen | Outperform |
2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
2020-12-14 | Eingeleitet | Jefferies | Buy |
2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2020-06-29 | Bestätigt | B. Riley FBR | Buy |
2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
2020-05-28 | Bestätigt | B. Riley FBR | Buy |
2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Menopause Treatment Market Opportunities, Challenges, - openPR
What is B. Riley's Estimate for Novavax FY2024 Earnings? - MarketBeat
Novavax to Present at Jefferies London Conference - TipRanks
Preventive Vaccines Market May Set New Growth Story | Takeda - openPR
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
How To Trade (NVAX) - Stock Traders Daily
FY2024 Earnings Forecast for Novavax Issued By HC Wainwright - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices
UK regulator approves adapted Novavax jab - The Pharma Letter
Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post
Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times
Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance
Novavax Grants Stock Options, RSUs to New R&D Chief in Executive Compensation Deal | NVAX Stock News - StockTitan
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - MSN
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance
Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com
Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Stock Experiences Significant Drop Amid Industry Volatility - GuruFocus.com
Protein-based Vaccine Sales Strategy Advances - Precision Vaccinations
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Stock Market Increases While Tesla And Novavax Take A Hit - Finimize
Novavax CEO to Present at Jefferies Healthcare Conference in London | NVAX Stock News - StockTitan
Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic P - GuruFocus.com
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Novavax Advances Vaccine Strategy Amid Financial Shifts - TipRanks
Earnings call: Novavax outlines strategic growth and partnership with Sanofi - Investing.com
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novavax Inc-Aktie (NVAX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Trizzino John | EVP, CCO and CBO |
Aug 19 '24 |
Option Exercise |
0.00 |
655 |
0 |
28,627 |
Kelly James Patrick | EVP, CFO and Treasurer |
Aug 16 '24 |
Option Exercise |
12.96 |
2,367 |
30,676 |
15,652 |
YOUNG JAMES F | Director |
Jun 21 '24 |
Sale |
14.09 |
7,500 |
105,675 |
61,760 |
YOUNG JAMES F | Director |
Jun 18 '24 |
Sale |
13.72 |
7,500 |
102,881 |
69,260 |
Dubovsky Filip | President, R&D |
Jun 17 '24 |
Option Exercise |
6.18 |
13,904 |
85,911 |
80,517 |
Dubovsky Filip | President, R&D |
Jun 17 '24 |
Sale |
14.47 |
13,904 |
201,164 |
66,613 |
MCGLYNN MARGARET G | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
10,470 |
Alton Gregg H | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
10,470 |
DOUGLAS RICHARD | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
43,920 |
King Rachel K. | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
18,920 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):